Acute shortage of equipment faced by pharma companies and rise in APIs to affect drug availability during COVID: Infomerics Read more
Japan approves Forxiga to treat chronic kidney disease in patients with and without type-II diabetes Read more
Approval of first interchangeable biosimilar insulin to increase competition with payer contracts: GlobalData Read more